This inventor holds 4 USPTO granted patents and 2 published patent applications and 1 EPO patent. Top assignees: Aventis Pharmaceuticals Inc., Aventis Pharmaceuticals Products Inc.. Active years: 2006-2014.
Company Filing History:
3 out of 207 
1 out of 23 Years Active: 2006-2014
Title: June M Kaplow: Innovator in Nuclear Factor Research
Introduction
June M Kaplow is a notable inventor based in Doylestown, PA (US). She has made significant contributions to the field of biomedical research, particularly in the area of nuclear factor kappa B (NFκB) induction. With a total of 4 patents, her work has implications for understanding and treating inflammatory responses.
Latest Patents
One of her latest patents focuses on nuclear factor kappa B (NFκB)-inducing factor polypeptides (NFIF polypeptides). This invention encompasses NFIF polypeptides, including NFIF-14b and NFIF-7a, as well as DNA, including cDNA, that encodes these polypeptides. The patent also details expression vectors capable of expressing NFIF polypeptides. Furthermore, it includes methods and compositions for increasing or lowering NFκB induction in patients, methods for inhibiting inflammation, and the manufacture of medicaments intended for the treatment and/or prevention of NFκB-regulated inflammatory responses. Additionally, the patent provides methods for determining whether a test compound inhibits or enhances the activity of NFIF polypeptides.
Career Highlights
June M Kaplow has worked with prominent companies in the pharmaceutical industry, including Aventis Pharmaceuticals Inc. and Aventis Pharmaceuticals Products Inc. Her experience in these organizations has contributed to her expertise in the development of innovative therapeutic solutions.
Collaborations
Throughout her career, she has collaborated with notable colleagues such as Patrice Denefle and Thomas F Haws. These partnerships have likely enriched her research and contributed to her success as an inventor.
Conclusion
June M Kaplow's contributions to the field of nuclear factor research highlight her innovative spirit and dedication to advancing medical science. Her patents and collaborations reflect her commitment to improving health outcomes through scientific discovery.